The metalloprotease ADAMTS4 generates N-truncated Aβ4–x species and marks oligodendrocytes as a source of amyloidogenic peptides in Alzheimer’s disease
Open accessAbstract
Brain accumulation and aggregation of amyloid-β (Aβ) peptides is a critical step in the pathogenesis of Alzheimer's disease (AD). Full-length Aβ peptides (mainly Aβ1-40 and Aβ1-42) are produced through sequential proteolytic cleavage of the amyloid precursor protein (APP) by β- and γ-secretases. However, studies of autopsy brain samples from AD patients have demonstrated that a large fraction of insoluble Aβ peptides are truncated at the N-terminus, with Aβ4-x peptides being particularly abundant. Aβ4-x peptides are highly aggregation prone, but their origin and any proteases involved in their generation are unknown. We have identified a recognition site for the secreted metalloprotease ADAMTS4 (a disintegrin and metalloproteinase with thrombospondin motifs 4) in the Aβ peptide sequence, which facilitates Aβ4-x peptide generation. Inducible overexpression of ADAMTS4 in HEK293 cells resulted in the secretion of Aβ4-40 but unchanged levels of Aβ1-x peptides. In the 5xFAD mouse model of amyloidosis, Aβ4-x peptides were present not only in amyloid plaque cores and vessel walls, but also in white matter structures co-localized with axonal APP. In the ADAMTS4-/- knockout background, Aβ4-40 levels were reduced confirming a pivotal role of ADAMTS4 in vivo. Surprisingly, in the adult murine brain, ADAMTS4 was exclusively expressed in oligodendrocytes. Cultured oligodendrocytes secreted a variety of Aβ species, but Aβ4-40 peptides were absent in cultures derived from ADAMTS4-/- mice indicating that the enzyme was essential for Aβ4-x production in this cell type. These findings establish an enzymatic mechanism for the generation of Aβ4-x peptides. They further identify oligodendrocytes as a source of these highly amyloidogenic Aβ peptides.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Cultured oligodendrocytes are capable of generating detectable levels of Aβ in vitro.
“Cultured oligodendrocytes (OLs) are capable of generating detectable levels of Aβ in vitro4–6.”
From Oligodendrocytes produce amyloid-β and contribute to plaque formation alongside neurons in Alzheimer’s disease model mice (2024) · cites this paper as [5]
ADAMTS4 is exclusively expressed in oligodendrocytes and produces strongly aggregating Aβ forms.
“ADAMTS4, exclusively expressed in oligodendrocytes, has been recently reported to produce strongly aggregating Aβ forms [139].”
From The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis? (2019) · cites this paper as [139]
The citation lists haven’t been fetched yet
References 84 · Cited by 65
- Authors
- Walter, S., Jumpertz, T., Hüttenrauch, M., Ogorek, I., Gerber, H., Storck, S. E., Zampar, S., Dimitrov, M., Lehmann, S., Lepka, K., Berndt, C., Wiltfang, J., Becker-Pauly, C., Beher, D., Pietrzik, C. U., Fraering, P. C., Wirths, O., & Weggen, S.
- Affiliations
- Heinrich Heine University Düsseldorf (DE)
- University of Göttingen (DE)
- University of Fribourg (CH)
- Johannes Gutenberg University Mainz (DE)
- École Polytechnique Fédérale de Lausanne (CH)
- Asceneuron (Switzerland) (CH)
- European Organization for Nuclear Research (CH)
- Corresponding author
- Wirths, Oliver
- Weggen, Sascha
- ORCID
- Venue
- Acta Neuropathologica
- Published
- 2018-11-13
- Volume
- 137
- Issue
- 2
- Pages
- 239-257
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2901207656
- Cited by
- 65
- References
- 84
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 7 · 2023: 10 · 2022: 5 · 2021: 18 · 2020: 7 · 2019: 4
- FWCI
- 4.97
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- cc-by-nc-nd
- www.springer.com/tdm (tdm)
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- reroDoc Digital Library (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Funders
- Stiftung VERUM
- Medizinische Fakultät, Heinrich-Heine-Universität Düsseldorf (9772513)
- Alzheimer Forschung Initiative (16013)
- Foundation Eclosion
- Foundation Strauss
- Foundation SFNTF
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Keywords
- ADAMTS-4, amyloid-beta, oligodendrocytes, Alzheimer's disease, amyloid precursor protein, metalloproteinases, proteolytic cleavage, amyloid plaques, white matter, 5xFAD mice, amyloidogenic peptides
- MeSH terms
- ADAMTS4 Protein, Alzheimer Disease, Animals, Brain, Disease Models, Animal, Humans, Oligodendroglia, Peptide Fragments, Amyloid beta-Peptides, Mice, Amyloid Precursor Protein Secretases, HEK293 Cells, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review